Tower Research Capital LLC (Trc) Syndax Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 6,509 shares of SNDX stock, worth $103,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,509

Previous 15,655 58.42%

Holding current value

$103,818

Previous $321,000 61.06%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.93 - $24.81 $163,987 - $226,912	-9,146 Reduced 58.42%	6,509 $125,000
Q2 2024 Aug 13, 2024	BUY	$18.82 - $23.79 $282,262 - $356,802	14,998 Added 2282.8%	15,655 $321,000
Q1 2024 May 15, 2024	SELL	$19.71 - $24.57 $51,817 - $64,594	-2,629 Reduced 80.01%	657 $15,000
Q4 2023 Feb 13, 2024	SELL	$11.39 - $21.67 $89,126 - $169,567	-7,825 Reduced 70.43%	3,286 $71,000
Q3 2023 Nov 14, 2023	BUY	$14.52 - $21.77 $51,996 - $77,958	3,581 Added 47.56%	11,111 $161,000
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $84,636 - $97,583	4,374 Added 138.59%	7,530 $157,000
Q1 2023 May 09, 2023	SELL	$20.66 - $28.98 $37,002 - $51,903	-1,791 Reduced 36.2%	3,156 $67,000
Q4 2022 Feb 10, 2023	SELL	$20.64 - $26.24 $47,224 - $60,037	-2,288 Reduced 31.62%	4,947 $126,000
Q3 2022 Nov 10, 2022	BUY	$18.51 - $24.79 $27,579 - $36,937	1,490 Added 25.94%	7,235 $174,000
Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $46,839 - $66,894	3,434 Added 148.59%	5,745 $111,000
Q1 2022 May 12, 2022	SELL	$14.84 - $22.15 $70,964 - $105,921	-4,782 Reduced 67.42%	2,311 $40,000
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $33,384 - $49,254	2,192 Added 44.73%	7,093 $155,000
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $12,580 - $17,958	-907 Reduced 15.62%	4,901 $94,000
Q2 2021 Aug 16, 2021	BUY	$13.42 - $25.18 $59,947 - $112,479	4,467 Added 333.11%	5,808 $100,000
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $4,742 - $6,049	246 Added 22.47%	1,341 $30,000
Q4 2020 Feb 16, 2021	SELL	$15.1 - $26.44 $240,829 - $421,691	-15,949 Reduced 93.58%	1,095 $24,000
Q3 2020 Nov 16, 2020	BUY	$13.39 - $17.48 $174,926 - $228,358	13,064 Added 328.24%	17,044 $252,000
Q2 2020 Aug 13, 2020	BUY	$8.94 - $20.98 $35,581 - $83,500	3,980 New	3,980 $59,000
Q4 2019 Feb 07, 2020	SELL	$5.43 - $9.22 $4,061 - $6,896	-748 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$7.47 - $10.76 $1,710 - $2,464	-229 Reduced 23.44%	748 $6,000
Q2 2019 Aug 13, 2019	SELL	$4.9 - $9.31 $21,981 - $41,764	-4,486 Reduced 82.12%	977 $9,000
Q1 2019 May 14, 2019	BUY	$4.26 - $6.86 $4,038 - $6,503	948 Added 21.0%	5,463 $29,000
Q4 2018 Feb 14, 2019	BUY	$3.6 - $8.42 $16,254 - $38,016	4,515 New	4,515 $20,000
Q3 2018 Nov 13, 2018	SELL	$6.33 - $8.08 $11,419 - $14,576	-1,804 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$6.93 - $14.63 $12,501 - $26,392	1,804 New	1,804 $13,000
Q4 2017 Feb 09, 2018	SELL	$7.8 - $12.94 $23,095 - $38,315	-2,961 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.9 - $12.73 $32,274 - $37,693	2,961	2,961 $35,000

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $902M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Syndax Pharmaceuticals Inc Transaction History